0.012580 0.000000 0.000000 0.000000 0.010279 0.000000 0.000000 0.000000 0.019736 0.00000 0.00000 0.00000 Ory, J. Kane, C.D. Simpson, M. Banaszak, L.J. Bernlohr, D.A. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic 8 90.00 90.00 90.00 79.490 97.290 50.670 C3 H7 N O2 89.093 y ALANINE L-peptide linking C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C4 H8 N2 O3 132.118 y ASPARAGINE L-peptide linking C4 H7 N O4 133.103 y ASPARTIC ACID L-peptide linking C3 H7 N O4 S 153.157 n 3-SULFINOALANINE S-CYSTEINESULFINIC ACID; S-SULFINOCYSTEINE L-peptide linking C3 H7 N O2 S 121.158 y CYSTEINE L-peptide linking C5 H10 N2 O3 146.144 y GLUTAMINE L-peptide linking C5 H9 N O4 147.129 y GLUTAMIC ACID L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H10 N3 O2 1 156.162 y HISTIDINE L-peptide linking C6 H13 N O2 131.173 y ISOLEUCINE L-peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking C5 H11 N O2 S 149.211 y METHIONINE L-peptide linking C9 H11 N O2 165.189 y PHENYLALANINE L-peptide linking C5 H9 N O2 115.130 y PROLINE L-peptide linking C3 H7 N O3 105.093 y SERINE L-peptide linking C4 H9 N O3 119.119 y THREONINE L-peptide linking C11 H12 N2 O2 204.225 y TRYPTOPHAN L-peptide linking C9 H11 N O3 181.189 y TYROSINE L-peptide linking C5 H11 N O2 117.146 y VALINE L-peptide linking US J.Biol.Chem. JBCHA3 0071 0021-9258 272 9793 9801 10.1074/jbc.272.15.9793 9092513 Biochemical and crystallographic analyses of a portal mutant of the adipocyte lipid-binding protein. 1997 10.2210/pdb1acd/pdb pdb_00001acd 1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 298 1 AREA DETECTOR 1994-04-22 SIEMENS GRAPHITE(002) M x-ray 1 1.5418 1.0 1.5418 ROTATING ANODE RIGAKU RUH2R 14532.526 ADIPOCYTE LIPID BINDING PROTEIN C1G, V32D, F57H 1 man polymer ALBP no yes GDAFVGTWKLVSSENFDDYMKEVGVGFATRKDAGMAKPNMIISVNGDLVTIRSESTHKNTEISFKLGVEFDEITADDRKV KSIITLDGGALVQVQKWDGKSTTIKRKRDGDKLVVE(CSD)VMKGVTSTRVYERA GDAFVGTWKLVSSENFDDYMKEVGVGFATRKDAGMAKPNMIISVNGDLVTIRSESTHKNTEISFKLGVEFDEITADDRKV KSIITLDGGALVQVQKWDGKSTTIKRKRDGDKLVVECVMKGVTSTRVYERA A polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n house mouse Mus Escherichia sample ADIPOCYTE 10090 Mus musculus 562 Escherichia coli 1 3.4 64.4 6.4 2.4M PHOSPHATE, PH 6.4 database_2 pdbx_database_status struct_conn struct_ref_seq_dif pdbx_initial_refinement_model repository Initial release Version format compliance Version format compliance Database references Derived calculations Other Refinement description 1 0 1997-06-16 1 1 2008-03-24 1 2 2011-07-13 1 3 2021-11-03 1 4 2023-08-02 _database_2.pdbx_DOI _database_2.pdbx_database_accession _pdbx_database_status.process_site _struct_conn.pdbx_leaving_atom_flag _struct_conn.ptnr1_auth_comp_id _struct_conn.ptnr1_auth_seq_id _struct_conn.ptnr1_label_atom_id _struct_conn.ptnr1_label_comp_id _struct_conn.ptnr1_label_seq_id _struct_conn.ptnr2_auth_comp_id _struct_conn.ptnr2_auth_seq_id _struct_conn.ptnr2_label_atom_id _struct_conn.ptnr2_label_comp_id _struct_conn.ptnr2_label_seq_id _struct_ref_seq_dif.details Y BNL 1997-02-06 REL REL 1LIB PDB ENTRY 1LIB PDB experimental model GLY 1 n 1 GLY 1 A ASP 2 n 2 ASP 2 A ALA 3 n 3 ALA 3 A PHE 4 n 4 PHE 4 A VAL 5 n 5 VAL 5 A GLY 6 n 6 GLY 6 A THR 7 n 7 THR 7 A TRP 8 n 8 TRP 8 A LYS 9 n 9 LYS 9 A LEU 10 n 10 LEU 10 A VAL 11 n 11 VAL 11 A SER 12 n 12 SER 12 A SER 13 n 13 SER 13 A GLU 14 n 14 GLU 14 A ASN 15 n 15 ASN 15 A PHE 16 n 16 PHE 16 A ASP 17 n 17 ASP 17 A ASP 18 n 18 ASP 18 A TYR 19 n 19 TYR 19 A MET 20 n 20 MET 20 A LYS 21 n 21 LYS 21 A GLU 22 n 22 GLU 22 A VAL 23 n 23 VAL 23 A GLY 24 n 24 GLY 24 A VAL 25 n 25 VAL 25 A GLY 26 n 26 GLY 26 A PHE 27 n 27 PHE 27 A ALA 28 n 28 ALA 28 A THR 29 n 29 THR 29 A ARG 30 n 30 ARG 30 A LYS 31 n 31 LYS 31 A ASP 32 n 32 ASP 32 A ALA 33 n 33 ALA 33 A GLY 34 n 34 GLY 34 A MET 35 n 35 MET 35 A ALA 36 n 36 ALA 36 A LYS 37 n 37 LYS 37 A PRO 38 n 38 PRO 38 A ASN 39 n 39 ASN 39 A MET 40 n 40 MET 40 A ILE 41 n 41 ILE 41 A ILE 42 n 42 ILE 42 A SER 43 n 43 SER 43 A VAL 44 n 44 VAL 44 A ASN 45 n 45 ASN 45 A GLY 46 n 46 GLY 46 A ASP 47 n 47 ASP 47 A LEU 48 n 48 LEU 48 A VAL 49 n 49 VAL 49 A THR 50 n 50 THR 50 A ILE 51 n 51 ILE 51 A ARG 52 n 52 ARG 52 A SER 53 n 53 SER 53 A GLU 54 n 54 GLU 54 A SER 55 n 55 SER 55 A THR 56 n 56 THR 56 A HIS 57 n 57 HIS 57 A LYS 58 n 58 LYS 58 A ASN 59 n 59 ASN 59 A THR 60 n 60 THR 60 A GLU 61 n 61 GLU 61 A ILE 62 n 62 ILE 62 A SER 63 n 63 SER 63 A PHE 64 n 64 PHE 64 A LYS 65 n 65 LYS 65 A LEU 66 n 66 LEU 66 A GLY 67 n 67 GLY 67 A VAL 68 n 68 VAL 68 A GLU 69 n 69 GLU 69 A PHE 70 n 70 PHE 70 A ASP 71 n 71 ASP 71 A GLU 72 n 72 GLU 72 A ILE 73 n 73 ILE 73 A THR 74 n 74 THR 74 A ALA 75 n 75 ALA 75 A ASP 76 n 76 ASP 76 A ASP 77 n 77 ASP 77 A ARG 78 n 78 ARG 78 A LYS 79 n 79 LYS 79 A VAL 80 n 80 VAL 80 A LYS 81 n 81 LYS 81 A SER 82 n 82 SER 82 A ILE 83 n 83 ILE 83 A ILE 84 n 84 ILE 84 A THR 85 n 85 THR 85 A LEU 86 n 86 LEU 86 A ASP 87 n 87 ASP 87 A GLY 88 n 88 GLY 88 A GLY 89 n 89 GLY 89 A ALA 90 n 90 ALA 90 A LEU 91 n 91 LEU 91 A VAL 92 n 92 VAL 92 A GLN 93 n 93 GLN 93 A VAL 94 n 94 VAL 94 A GLN 95 n 95 GLN 95 A LYS 96 n 96 LYS 96 A TRP 97 n 97 TRP 97 A ASP 98 n 98 ASP 98 A GLY 99 n 99 GLY 99 A LYS 100 n 100 LYS 100 A SER 101 n 101 SER 101 A THR 102 n 102 THR 102 A THR 103 n 103 THR 103 A ILE 104 n 104 ILE 104 A LYS 105 n 105 LYS 105 A ARG 106 n 106 ARG 106 A LYS 107 n 107 LYS 107 A ARG 108 n 108 ARG 108 A ASP 109 n 109 ASP 109 A GLY 110 n 110 GLY 110 A ASP 111 n 111 ASP 111 A LYS 112 n 112 LYS 112 A LEU 113 n 113 LEU 113 A VAL 114 n 114 VAL 114 A VAL 115 n 115 VAL 115 A GLU 116 n 116 GLU 116 A CSD 117 n 117 CSD 117 A VAL 118 n 118 VAL 118 A MET 119 n 119 MET 119 A LYS 120 n 120 LYS 120 A GLY 121 n 121 GLY 121 A VAL 122 n 122 VAL 122 A THR 123 n 123 THR 123 A SER 124 n 124 SER 124 A THR 125 n 125 THR 125 A ARG 126 n 126 ARG 126 A VAL 127 n 127 VAL 127 A TYR 128 n 128 TYR 128 A GLU 129 n 129 GLU 129 A ARG 130 n 130 ARG 130 A ALA 131 n 131 ALA 131 A author_defined_assembly 2 dimeric A CSD 117 3-SULFINOALANINE A CSD 117 CYS 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 x,y,z identity operation 0.0000000000 0.0000000000 0.0000000000 -1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 -1.0000000000 3_653 -x+1,y,-z-3/2 crystal symmetry operation 79.4900000000 0.0000000000 -76.0050000000 A O THR 60 A O THR 60 A N SER 53 A N SER 53 A O LEU 48 A O LEU 48 A N ASN 45 A N ASN 45 A O MET 40 A O MET 40 A N TRP 8 A N TRP 8 A O LYS 9 A O LYS 9 A N GLU 129 A N GLU 129 A O ARG 126 A O ARG 126 A N VAL 115 A N VAL 115 A O LYS 112 A O LYS 112 A N ASP 109 A N ASP 109 A O LYS 100 A O LYS 100 A N TRP 97 A N TRP 97 A O ALA 90 A O ALA 90 A N ASP 87 A N ASP 87 A O VAL 80 A O VAL 80 A N GLU 72 A N GLU 72 1 A CG LYS 9 A CG LYS 9 0 Y 1 A CD LYS 9 A CD LYS 9 0 Y 1 A CE LYS 9 A CE LYS 9 0 Y 1 A NZ LYS 9 A NZ LYS 9 0 Y 1 A NZ LYS 21 A NZ LYS 21 0 Y 1 A CB MET 35 A CB MET 35 0 Y 1 A CG MET 35 A CG MET 35 0 Y 1 A SD MET 35 A SD MET 35 0 Y 1 A CE MET 35 A CE MET 35 0 Y 1 A CB HIS 57 A CB HIS 57 0 Y 1 A CG HIS 57 A CG HIS 57 0 Y 1 A ND1 HIS 57 A ND1 HIS 57 0 Y 1 A CD2 HIS 57 A CD2 HIS 57 0 Y 1 A CE1 HIS 57 A CE1 HIS 57 0 Y 1 A NE2 HIS 57 A NE2 HIS 57 0 Y 1 A CE LYS 96 A CE LYS 96 0 Y 1 A NZ LYS 96 A NZ LYS 96 0 Y 1 A NZ LYS 120 A NZ LYS 120 0 Y 1 A THR 56 -63.57 13.75 1 A HIS 57 -162.03 -55.60 1 A GLU 61 -170.83 143.46 1 A ASP 109 -150.62 86.80 1 A LYS 120 28.42 81.71 PARHCSDX.PRO TOPHCSDX.PRO CYO.PARAM CYO.TOPPAR 27.6 0.2760000 0.0004 0.1980000 0.1980000 2.70 30.0 514 4452 10.1 78.8 RANDOM 1000000. 0.001 1 RESTRAINED THROUGHOUT 2.0 MOLECULAR REPLACEMENT PDB ENTRY 1LIB 0.574 0.41 30.0 0.280 0.22 2.70 30.0 0 1017 0 0 1017 0.010 1.56 26.7 1.21 0.3250000 0.000 0.3240000 2.82 19 145 8 2.76 23.9 54.2 2.7 30.0 1ACD 26696 2. 0.0960000 1 10.4 5.0 97.2 2.70 2.86 0.99 0.4190000 2.0 57.3 model building X-PLOR refinement X-PLOR data reduction XENGEN data scaling XENGEN phasing X-PLOR V32D/F57H MUTANT OF MURINE ADIPOCYTE LIPID BINDING PROTEIN 1 N N A PHE 16 A PHE 16 HELX_P A VAL 23 A VAL 23 1 1 8 A PHE 27 A PHE 27 HELX_P A ALA 33 A ALA 33 1 2 7 covale 1.333 both A GLU 116 A C GLU 116 1_555 A CSD 117 A N CSD 117 1_555 covale 1.332 both A CSD 117 A C CSD 117 1_555 A VAL 118 A N VAL 118 1_555 FATTY ACID BINDING PROTEIN FATTY ACID BINDING PROTEIN FABPA_MOUSE UNP 1 1 P04117 CDAFVGTWKLVSSENFDDYMKEVGVGFATRKVAGMAKPNMIISVNGDLVTIRSESTFKNTEISFKLGVEFDEITADDRKV KSIITLDGGALVQVQKWDGKSTTIKRKRDGDKLVVECVMKGVTSTRVYERA 2 131 1ACD 2 131 P04117 A 1 2 131 1 VAL engineered mutation ASP 32 1ACD A P04117 UNP 32 32 1 PHE engineered mutation HIS 57 1ACD A P04117 UNP 57 57 1 CYS modified residue CSD 117 1ACD A P04117 UNP 117 117 10 anti-parallel anti-parallel anti-parallel anti-parallel anti-parallel anti-parallel anti-parallel anti-parallel anti-parallel A THR 60 A THR 60 A PHE 64 A PHE 64 A LEU 48 A LEU 48 A GLU 54 A GLU 54 A ASN 39 A ASN 39 A ASN 45 A ASN 45 A GLY 6 A GLY 6 A GLU 14 A GLU 14 A THR 125 A THR 125 A ARG 130 A ARG 130 A LYS 112 A LYS 112 A GLU 116 A GLU 116 A LYS 100 A LYS 100 A ASP 109 A ASP 109 A ALA 90 A ALA 90 A TRP 97 A TRP 97 A LYS 79 A LYS 79 A ASP 87 A ASP 87 A PHE 70 A PHE 70 A ILE 73 A ILE 73 MUTATED PORTAL REGION, PROPOSED SITE OF LIGAND ENTRY. Unknown 2 A ASP 32 A ASP 32 2 1_555 A HIS 57 A HIS 57 2 1_555 20 C 2 2 21